Giana Montero Garnier

Title: Giana Montero Garnier: Innovator in Cancer Treatment Technology

Introduction

Giana Montero Garnier is a prominent inventor based in Alameda, CA, who has made significant contributions to the field of cancer treatment. She holds a patent for innovative devices and methods aimed at modulating immune system activity in cancer patients. Her work focuses on enhancing the body's natural defenses against cancer through advanced medical technology.

Latest Patents

Giana Montero Garnier is credited with a patent titled "Devices and methods for modulating immune system activity in a cancer patient and treating cancer." This patent describes methods and devices designed to monitor or modulate the immune system in individuals diagnosed with cancer. The technology involves an implanted device that electrically stimulates the splenic nerve, which can influence the inflammatory response by adjusting the levels of pro-inflammatory and anti-inflammatory cytokines. This modulation can enhance the circulation of immune cells, such as natural killer cells and cytotoxic T-cells, thereby improving cancer treatment outcomes. The device is equipped with multiple electrodes for nerve stimulation and may include an ultrasonic transducer to convert ultrasonic energy into electrical energy for device operation.

Career Highlights

Giana is associated with Iota Biosciences, Inc., where she applies her expertise in developing cutting-edge medical devices. Her innovative approach to cancer treatment has positioned her as a key figure in the intersection of technology and healthcare.

Collaborations

Giana has collaborated with notable professionals in her field, including Jose M Carmena and Michel Martin Maharbiz. These partnerships have furthered her research and development efforts, contributing to advancements in cancer treatment technologies.

Conclusion

Giana Montero Garnier's work exemplifies the potential of innovative medical devices in transforming cancer treatment. Her patented technology represents a significant step forward in harnessing the immune system to combat cancer effectively.